BioSpace News Archive

Chrysalis BioTherapeutics, Inc. announced today that the US Food and Drug Administration (FDA) has given the company permission to initiate human clinical trials aimed at treating acute lung failure.

PLT Health Solutions, Inc. announced that it has received an expanded license from the Natural and Non-Prescription Health Products Directorate (NNHPD) of Health Canada to market its ingredient AlvioLife® to support respiratory health in Canada.

Arcturus Therapeutics Holdings Inc. (the announced today that Arcturus and the Cystic Fibrosis Foundation (CF Foundation) have extended their ongoing agreement.

The Cystic Fibrosis Foundation is investing up to $9 million in additional funds in Arcturus Therapeutics to test an inhaled messenger RNA (mRNA) therapy that could treat the underlying cause of cystic fibrosis in all people living with the disease, including those with two copies of rare and nonsense mutations.

Curio Bioscience today announced an expansion of its Curio Seeker product line with a larger format to deliver a more complete view of large biological structures, including human tissue samples, providing one hundred times more data compared to other whole transcriptome spatial analysis solutions.

Neogen Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release before the opening of the market on Tuesday, October 10, 2023.

Saluda Medical, Inc. (“Saluda Medical”) today announced that the U.S. Food and Drug Administration (FDA) has approved MRI conditional labeling for the Evoke® System, the first and only precision, dose-control spinal cord stimulation (SCS) therapy powered by SmartLoop™ technology.